NYVClass II
Gastrointestinal Motility System, Capsule
21 CFR 876.1725 / Gastroenterology, Urology
NYV is the FDA product code for Gastrointestinal Motility System, Capsule, a class II device type, regulated under 21 CFR 876.1725. FDA's definition for this code reads: "Used to evaluate GI motility disorders and indicated for use in evaluating patients with suspected motility disorders". As of , FDA records hold 5 510(k) clearances under this code, the most recent dated , and no recalls.
Classification record
- Product code
- NYV
- Device name
- Gastrointestinal Motility System, Capsule
- FDA definition
- Used to evaluate GI motility disorders and indicated for use in evaluating patients with suspected motility disorders.
- Regulation
- 21 CFR 876.1725
- Device class
- Class II
- Review panel
- Gastroenterology, Urology
- Submission type
- 510(k)
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- No
- Ingested clearances
- 5
- Ingested recalls
- 0
Clearances, product code NYV
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 2006 | 1 |
| 2009 | 1 |
| 2025 | 2 |
| 2026 | 1 |
Applicants with the most clearances
Product code NYV| Applicant | Clearances |
|---|---|
| Atmo Biosciences Ltd | 2 |
| The Smartpill Corporation | 2 |
| Anx Robotica Corp. | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
